Clinical and genomic characteristics of metabolic syndrome in colorectal cancer

Metabolic syndrome (MetS) is characterized by a group of metabolic disturbances which leads to the enhanced risk of cancer development. Elucidating the mechanisms between these two pathologies is essential to identify the potential therapeutic molecular targets for colorectal cancer (CRC). 716 color...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanyan, Zhao, Jungang, Wu, Xiaoli, Zhang, Yini, Jin, Yin, Cai, Weiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950286/
https://www.ncbi.nlm.nih.gov/pubmed/33582655
http://dx.doi.org/10.18632/aging.202474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950286/
https://www.ncbi.nlm.nih.gov/pubmed/33582655
http://dx.doi.org/10.18632/aging.202474

Ejemplares similares